Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus

Detalhes bibliográficos
Autor(a) principal: Moroti, Camila [UNESP]
Data de Publicação: 2012
Outros Autores: Souza Magri, Loyanne Francine [UNESP], Costa, Marcela de Rezende [UNESP], Cavallini, Daniela Cardoso Umbelino [UNESP], Sivieri, Katia [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1186/1476-511X-11-29
http://hdl.handle.net/11449/7208
Resumo: Background: The consumption of foods containing probiotic and prebiotic ingredients is growing consistently every year, and in view of the limited number of studies investigating their effect in the elderly.Objective: The objective of this study was to evaluate the effect of the consumption of a symbiotic shake containing Lactobacillus acidophilus, Bifidobacterium bifidum and fructooligosaccharides on glycemia and cholesterol levels in elderly people.Methods: A randomized, double-blind, placebo-controlled study was conducted on twenty volunteers (ten for placebo group and ten for symbiotic group), aged 50 to 60 years. The criteria for inclusion in the study were: total cholesterol > 200 mg/dL; triglycerides > 200 mg/dL and glycemia > 110 mg/dL. Over a total test period of 30 days, 10 individuals (the symbiotic group) consumed a daily dose of 200 mL of a symbiotic shake containing 10(8) UFC/mL Lactobacillus acidophilus, 10(8) UFC/mL Bifidobacterium bifidum and 2 g oligofructose, while 10 other volunteers (the placebo group) drank daily the same amount of a shake that did not contain any symbiotic bacteria. Blood samples were collected 15 days prior to the start of the experiment and at 10-day intervals after the beginning of the shake intake. The standard lipid profile (total cholesterol, triglycerides and HDL cholesterol) and glycemia, or blood sugar levels, were evaluated by an enzyme colorimetric assay.Results: The results of the symbiotic group showed a non-significant reduction (P > 0.05) in total cholesterol and triglycerides, a significant increase (P < 0.05) in HDL cholesterol and a significant reduction (P < 0.05) in fasting glycemia. No significant changes were observed in the placebo group.Conclusion: The consumption of symbiotic shake resulted in a significant increase in HDL and a significant decrease of glycemia.
id UNSP_32b212c1cf75dd9fc0785e11b7f2f8b5
oai_identifier_str oai:repositorio.unesp.br:11449/7208
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitusBifidobacterium bifidumFructooligosaccharideLactobacillus acidophilusSymbioticsShakeBackground: The consumption of foods containing probiotic and prebiotic ingredients is growing consistently every year, and in view of the limited number of studies investigating their effect in the elderly.Objective: The objective of this study was to evaluate the effect of the consumption of a symbiotic shake containing Lactobacillus acidophilus, Bifidobacterium bifidum and fructooligosaccharides on glycemia and cholesterol levels in elderly people.Methods: A randomized, double-blind, placebo-controlled study was conducted on twenty volunteers (ten for placebo group and ten for symbiotic group), aged 50 to 60 years. The criteria for inclusion in the study were: total cholesterol > 200 mg/dL; triglycerides > 200 mg/dL and glycemia > 110 mg/dL. Over a total test period of 30 days, 10 individuals (the symbiotic group) consumed a daily dose of 200 mL of a symbiotic shake containing 10(8) UFC/mL Lactobacillus acidophilus, 10(8) UFC/mL Bifidobacterium bifidum and 2 g oligofructose, while 10 other volunteers (the placebo group) drank daily the same amount of a shake that did not contain any symbiotic bacteria. Blood samples were collected 15 days prior to the start of the experiment and at 10-day intervals after the beginning of the shake intake. The standard lipid profile (total cholesterol, triglycerides and HDL cholesterol) and glycemia, or blood sugar levels, were evaluated by an enzyme colorimetric assay.Results: The results of the symbiotic group showed a non-significant reduction (P > 0.05) in total cholesterol and triglycerides, a significant increase (P < 0.05) in HDL cholesterol and a significant reduction (P < 0.05) in fasting glycemia. No significant changes were observed in the placebo group.Conclusion: The consumption of symbiotic shake resulted in a significant increase in HDL and a significant decrease of glycemia.São Paulo State Univ, Sch Pharmaceut Sci, Dept Food & Nutr, Araraquara, SP, BrazilUniv Estadual, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, BR-14802901 Araraquara, SP, BrazilSão Paulo State Univ, Sch Pharmaceut Sci, Dept Food & Nutr, Araraquara, SP, BrazilBiomed Central Ltd.Universidade Estadual Paulista (Unesp)Univ EstadualMoroti, Camila [UNESP]Souza Magri, Loyanne Francine [UNESP]Costa, Marcela de Rezende [UNESP]Cavallini, Daniela Cardoso Umbelino [UNESP]Sivieri, Katia [UNESP]2014-05-20T13:23:43Z2014-05-20T13:23:43Z2012-02-22info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article8application/pdfhttp://dx.doi.org/10.1186/1476-511X-11-29Lipids In Health and Disease. London: Biomed Central Ltd., v. 11, p. 8, 2012.1476-511Xhttp://hdl.handle.net/11449/720810.1186/1476-511X-11-29WOS:000301590800001WOS000301590800001.pdfWeb of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengLipids in Health and Disease2.663info:eu-repo/semantics/openAccess2025-03-29T05:29:07Zoai:repositorio.unesp.br:11449/7208Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-03-29T05:29:07Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
spellingShingle Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
Moroti, Camila [UNESP]
Bifidobacterium bifidum
Fructooligosaccharide
Lactobacillus acidophilus
Symbiotics
Shake
title_short Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_full Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_fullStr Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_full_unstemmed Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
title_sort Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
author Moroti, Camila [UNESP]
author_facet Moroti, Camila [UNESP]
Souza Magri, Loyanne Francine [UNESP]
Costa, Marcela de Rezende [UNESP]
Cavallini, Daniela Cardoso Umbelino [UNESP]
Sivieri, Katia [UNESP]
author_role author
author2 Souza Magri, Loyanne Francine [UNESP]
Costa, Marcela de Rezende [UNESP]
Cavallini, Daniela Cardoso Umbelino [UNESP]
Sivieri, Katia [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Univ Estadual
dc.contributor.author.fl_str_mv Moroti, Camila [UNESP]
Souza Magri, Loyanne Francine [UNESP]
Costa, Marcela de Rezende [UNESP]
Cavallini, Daniela Cardoso Umbelino [UNESP]
Sivieri, Katia [UNESP]
dc.subject.por.fl_str_mv Bifidobacterium bifidum
Fructooligosaccharide
Lactobacillus acidophilus
Symbiotics
Shake
topic Bifidobacterium bifidum
Fructooligosaccharide
Lactobacillus acidophilus
Symbiotics
Shake
description Background: The consumption of foods containing probiotic and prebiotic ingredients is growing consistently every year, and in view of the limited number of studies investigating their effect in the elderly.Objective: The objective of this study was to evaluate the effect of the consumption of a symbiotic shake containing Lactobacillus acidophilus, Bifidobacterium bifidum and fructooligosaccharides on glycemia and cholesterol levels in elderly people.Methods: A randomized, double-blind, placebo-controlled study was conducted on twenty volunteers (ten for placebo group and ten for symbiotic group), aged 50 to 60 years. The criteria for inclusion in the study were: total cholesterol > 200 mg/dL; triglycerides > 200 mg/dL and glycemia > 110 mg/dL. Over a total test period of 30 days, 10 individuals (the symbiotic group) consumed a daily dose of 200 mL of a symbiotic shake containing 10(8) UFC/mL Lactobacillus acidophilus, 10(8) UFC/mL Bifidobacterium bifidum and 2 g oligofructose, while 10 other volunteers (the placebo group) drank daily the same amount of a shake that did not contain any symbiotic bacteria. Blood samples were collected 15 days prior to the start of the experiment and at 10-day intervals after the beginning of the shake intake. The standard lipid profile (total cholesterol, triglycerides and HDL cholesterol) and glycemia, or blood sugar levels, were evaluated by an enzyme colorimetric assay.Results: The results of the symbiotic group showed a non-significant reduction (P > 0.05) in total cholesterol and triglycerides, a significant increase (P < 0.05) in HDL cholesterol and a significant reduction (P < 0.05) in fasting glycemia. No significant changes were observed in the placebo group.Conclusion: The consumption of symbiotic shake resulted in a significant increase in HDL and a significant decrease of glycemia.
publishDate 2012
dc.date.none.fl_str_mv 2012-02-22
2014-05-20T13:23:43Z
2014-05-20T13:23:43Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1476-511X-11-29
Lipids In Health and Disease. London: Biomed Central Ltd., v. 11, p. 8, 2012.
1476-511X
http://hdl.handle.net/11449/7208
10.1186/1476-511X-11-29
WOS:000301590800001
WOS000301590800001.pdf
url http://dx.doi.org/10.1186/1476-511X-11-29
http://hdl.handle.net/11449/7208
identifier_str_mv Lipids In Health and Disease. London: Biomed Central Ltd., v. 11, p. 8, 2012.
1476-511X
10.1186/1476-511X-11-29
WOS:000301590800001
WOS000301590800001.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Lipids in Health and Disease
2.663
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 8
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd.
publisher.none.fl_str_mv Biomed Central Ltd.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1834482469007523840